Decitabine (Accord Healthcare Inc.)
Welcome to the PulseAid listing for the Decitabine drug offered from Accord Healthcare Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Accord Healthcare Inc. |
| NON-PROPRIETARY NAME: | decitabine |
| SUBSTANCE NAME: | DECITABINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-03-08 |
| END MARKETING DATE: | 0000-00-00 |
Decitabine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Decitabine from Accord Healthcare Inc. |
| LABELER NAME: | Accord Healthcare Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/20mL) |
| START MARKETING DATE: | 2017-03-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 16729-224_4a4fdf61-c80b-06db-e054-00144ff88e88 |
| PRODUCT NDC: | 16729-224 |
| APPLICATION NUMBER: | ANDA203475 |
Other DECITABINE Pharmaceutical Manufacturers / Labelers:
